Avian-flu vaccine makers receive immunity from liability lawsuits

Share this article:
The Bush administration has triggered a provision of a 2005 law that protects companies producing vaccines or drugs made in connection with avian-flu from product-liability lawsuits. The law gives the Secretary of Health and Human Services power to grant immunity to vaccine and drug makers in the event of a risk to public health. In a directive last week, HHS invoked the clause, “based on a credible risk that an avian- influenza virus spreads and evolves into a strain capable of causing a pandemic of human influenza.” Bill Hall, an HHS spokesman told The Wall Street Journal, the agency’s declaration “allows us to remove the remaining barrier to building up our domestic capacity to manufacturers of vaccines in a flu pandemic.” Hall denied to The Journal that the move reflected heightened concern about the avian flu. Rather, he said, “It was a precautionary step.” As part of a plan to spur development of experimental vaccines and other countermeasures against bioterrorism threats, Congress passed the bill in late 2005 to provide liability protection to those vaccine makers. The measure was signed by President Bush in December 2005 but was met with criticism by some trial lawyers and lawmakers as a giveaway to drug companies.
Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.